Patent · US Active

Targeted transposition for use in epigenetic studies

US12049622B2 · kind B2 · utility

0Cited by

6References

48Claims

0Family size

Assignee

ACTIVE MOTIF, INC. · US

Inventors

Mary Anne Jelinek · Carlsbad, US
Brian Stanley Egan · Redding, US
Joseph Fernandez · Carlsbad, US

Key dates

Filing date	Mar 25, 2022
Grant date	Jul 30, 2024
Priority date	—
Expiry date	May 4, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q1/6806
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Disclosed herein are compositions, methods and kits useful for epigenetic analysis based on the use of transposons that are targeted to specific regions of chromatin based on DNA-DNA interactions, protein-protein interactions, RNA-RNA interactions, and nucleic acid-protein interactions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.